Synthesis method of celecoxib

A synthesis method and a condensation reaction technology are applied in the field of preparation of celecoxib, which can solve the problems of affecting product quality and yield, low celecoxib yield and the like, and achieve a sufficient reaction, improved competitiveness and less impurities. Effect

Inactive Publication Date: 2012-03-28
JIANGXI SYNERGY PHARMA
View PDF3 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The yield of this process celecoxib is low, only 46%; The main reason is that using sodium methylate as a catalyst fails to react completely, and the diketone without separation contai

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of celecoxib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Preparation of 1-(4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione

[0024] Put 400ml of toluene and 25g of sodium hydride into a 1000ml four-necked bottle successively, stir, raise the temperature to 60~65°C, add 40g of p-methylacetophenone dropwise, and simultaneously add 50g of ethyl trifluoroacetate dropwise. After dropping, keep warm at 60-65°C for 1 hour, cool to 30°C, add 120ml of 15% hydrochloric acid dropwise, let stand and separate after dropping, and evaporate the organic layer to dryness under reduced pressure to obtain the residue 1-(4-methyl 65.9 g of phenyl)-4,4,4-trifluoro-1,3-butanedione, yield 96%.

Embodiment 2

[0026] Preparation of 1-(4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione

[0027] Put 400ml of toluene and 25g of sodium hydrogen into a 1000ml four-necked bottle successively, stir, control the temperature to 20~25°C, add 40g of p-methylacetophenone dropwise, and simultaneously add 50g of ethyl trifluoroacetate dropwise. After dripping, keep it warm at 40-45°C for 5 hours, cool to 30°C, add 120ml of 15% hydrochloric acid dropwise, let stand to separate after dripping, evaporate the organic layer to dryness under reduced pressure, and add 200ml of petroleum ether to the residue to crystallize 1- (4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione 62.3g, yield 91%.

Embodiment 3

[0029] Preparation of 1-(4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione

[0030] Put 400ml of toluene and 40g of potassium hydride into a 1000ml four-neck bottle successively, stir, control the temperature to 5~10°C, add 40g of p-methylacetophenone dropwise, and simultaneously add 50g of ethyl trifluoroacetate dropwise. After dropping, keep warm at 30-35°C for 6 hours, cool to 30°C, add 120ml of 15% hydrochloric acid dropwise, let stand and separate after dropping, evaporate the organic layer to dryness under reduced pressure, and add 200ml of petroleum ether to the residue to crystallize 1- (4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione 59g, yield 86%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthesis method of celecoxib, which comprises the following specific steps of: 1, carrying out claisen condensation on p-methylacetophenone and trifluoroacetic acid ethyl esters in an aprotic organic solvent under the catalysis of alkali to obtain 1-(4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione; and 2, reacting the obtained 1-(4-methylphenyl)-4,4,4-trifluoro-1,3-butanedione with sulfonamide-phenylhydrazine hydrochloride to obtain celecoxib, wherein in the step 1, the alkali for catalysis is selected from one or more of sodium hydride, potassium hydride, lithium hydride and calcium hydride. The synthesis method of celecoxib provided by the invention is easy to operate, high in yield, high in product purity and easy for industrial production.

Description

technical field [0001] The present invention relates to the field of organic chemistry, in particular to a preparation method of Celecoxib. Background technique [0002] Celecoxib, molecular formula: C 17 h 14 f 3 N 3 o 2 S, with a molecular weight of 381, is a compound of chemical formula (1), and its chemical name is: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl] Benzenesulfonamide (CAS Registry No. 169590-42-5). Celecoxib is a highly selective COX-2 inhibitor. It is a new type of antipyretic, analgesic and anti-inflammatory drug with high efficiency and low toxicity. It is used for the treatment of rheumatoid arthritis, osteoarthritis and other inflammatory pains. Since it was launched on the market, the drug has shown the advantages of definite curative effect, mild and few adverse reactions. [0003] The preparation method of celecoxib was first disclosed by (WO95 / 15316) as follows: [0004] [0005] 1 [0006] The process is to obtain 1-(4-methylp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D231/12
Inventor 蒋慧纲蒋元森徐烘材
Owner JIANGXI SYNERGY PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap